Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation problems in liver disease.

S I Rapaport1

  • 1University of California, San Diego, USA. srapaport@ucsd.edu

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|June 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The multiple faces of the partial thromboplastin time APTT.

Journal of thrombosis and haemostasis : JTH·2004
Same author

A novel clotting assay for quantitation of plasma prothrombin (factor II) using Echis multisquamatus venom.

American journal of clinical pathology·1999
Same author

Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation.

The American journal of physiology·1998
Same author

A Protac-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1997
Same author

Presentation of the 1997 George M. Kober Medal to Helen Ranney.

Proceedings of the Association of American Physicians·1997
Same author

Correction of excessive anticoagulation with low-dose oral vitamin K1.

Annals of internal medicine·1997
Same journal

Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
See all related articles

This study explores abnormal hemostasis in cirrhosis, its evaluation, and the impact of recombinant activated factor VII (rFVIIa) on blood coagulation. Findings enhance understanding of rFVIIa

Area of Science:

  • Hematology
  • Hepatology
  • Pharmacology

Background:

  • Cirrhosis frequently causes abnormal hemostasis, complicating patient management.
  • Evaluating hemostatic function is critical before invasive procedures and during bleeding events in cirrhotic patients.

Purpose of the Study:

  • To investigate the causes of abnormal hemostasis in cirrhosis.
  • To outline methods for evaluating hemostasis in cirrhotic patients.
  • To assess the effect of recombinant activated factor VII (rFVIIa) on hemostatic function in cirrhosis.

Main Methods:

  • Review of causes for abnormal hemostasis in cirrhosis.
  • Description of hemostasis evaluation techniques for cirrhotic patients.
  • Laboratory experiments detailing the impact of rFVIIa on blood coagulation.

Related Experiment Videos

Main Results:

  • Elucidation of hemostatic abnormalities associated with cirrhosis.
  • Characterization of rFVIIa's influence on blood coagulation parameters in cirrhotic models.

Conclusions:

  • Understanding cirrhosis-related hemostatic dysfunction is crucial.
  • rFVIIa demonstrates potential effects on hemostasis in cirrhotic patients, warranting further investigation.
  • Laboratory findings provide insights into rFVIIa's mechanism in cirrhotic coagulation.